Latest news with #MEG
The Irish Sun
5 days ago
- Entertainment
- The Irish Sun
Horoscope today, July 25, 2025: Daily star sign guide from Mystic Meg
OUR much-loved astrologer Meg sadly died in 2023 but her column will be kept alive by her friend and protégée Maggie Innes. Read on to see what's written in the stars for you today. ♈ ARIES March 21 to April 20 That Friday feeling can get you thinking of faces and places you've been missing – and this is a great time to follow through. You have a chart of new beginnings that can help you rewrite the past and rework relationships. READ MORE MYSTIC MEG So let your natural winning streak take charge and follow where your ideas lead you. 3 Your weekly horoscope for Friday ♉ TAURUS April 21 to May 21 The sun spars with Pluto, and big home-based decisions can come into the crossfire – but in ways that leave you richer. Trying to ignore a gap that's growing wider does not suit your straightforward Taurus self. When you need strength to deal with this, it is there. Luck circles recently-changed names. Get all the latest Taurus horoscope news including your weekly and monthly predictions ♊ GEMINI May 22 to June 21 Talking about yourself in ways that impress and intrigue is a key factor of your chart. So get your words ready and start speaking. If you're in love, accepting that changes may be small, but are heading in the right direction, is your star skill. Single? Your soulmate has a familiar voice. Get all the latest Gemini horoscope news including your weekly and monthly predictions ♋ CANCER June 22 to July 22 As the sun and Mercury form a formidable money team, you can find new ways to deal with old cash questions. You can get more time or help, provided you're not too proud to make the request. As for love, there's a dreamy aspect to your chart that helps partners reconnect. Fresh romance can link to a former workplace. Get all the latest Cancer horoscope news including your weekly and monthly predictions ♌ LEO July 23 to August 23 Knowing the difference between self-criticism and self-support is your chart secret. Being extra hard on yourself may feel necessary for success, but when you look again, you can see a different way that asks you to believe in your own ability. A good friend's love story can include a surprise starring role for you. Get all the latest Leo horoscope news including your weekly and monthly predictions Most read in The Irish Sun ♍ VIRGO August 24 to September 22 That half-truth or half-hope that has been on your mind needs addressing. Finding out more, with no obligation, is easier with your current chart combination of caring and questioning. Passion, all day, is positively popping – especially when you meet someone in dark clothing, or in a darkened space. Get all the latest Virgo horoscope news including your weekly and monthly predictions 3 In love? Switch roles for a while and have some fun Credit: Getty ♎ LIBRA September 23 to October 23 Love lessons may not have been easy to learn, but you are nearing the end of the process – plus the chance to put your new knowledge and ability into practice. Try not to waste this chance. Friends who work together well can also win together well – and a second-time-around contest can be the key. Get all the latest Libra horoscope news including your weekly and monthly predictions List of 12 star signs The traditional dates used by Mystic Meg for each sign are below. Capricorn: Aquarius: Pisces: Aries: Taurus: Gemini: Cancer: Leo: Virgo : Libra: Scorpio: Sagittarius: ♏ SCORPIO October 24 to November 22 As the moon and sun travel in tandem, two very different sides of you can take centre stage. First, your hunger for change, but in ways that really fulfil you. And second, a need to keep certain parts of your life exactly as they are. The right balance is in your own hands, and can happen now. Luck opens a yellow door. Get all the latest Scorpio horoscope news including your weekly and monthly predictions ♐ SAGITTARIUS November 23 to December 21 Your deep inner travelling spirit is waking up – ready to start moving forward. A time when you have had to shelve ambitious relocation plans can end when you take just one step in the desired direction. You also have the patience now to wait and see, when you need to. In love terms, doing anything is better than doing nothing. Get all the latest Sagittarius horoscope news including your weekly and monthly predictions ♑ CAPRICORN December 22 to January 20 People who assume a creative career is out of your reach can be thinking again. The way you dig deep into your skills, and are ready to develop them, shows your determination. Do take on board any advice or assistance offers. Love-wise, when you feel most alone is exactly when a special name is thinking of you. Get all the latest Capricorn horoscope news including your weekly and monthly predictions 3 A communication moon opens two hearts at once Credit: Supplied ♒ AQUARIUS January 21 to February 18 Your image is important to you – but is it accurate? If you're in love, that cool front may need to thaw a little to let a partner in. If you're single, playing hard to get can push the right partner away – so if you feel something for someone, don't be scared to show it. An 'S' conversation can have a sudden twist. Get all the latest Aquarius horoscope news including your weekly and monthly predictions ♓ PISCES February 19 to March 20 How a family works and plays together is ready for a revamp – habits can be good, but not if they trap you in a tricky situation. Just one smart suggestion can be all it takes to break the mould. At work, the sun and Mercury set high standards, but you are more than ready to be tested, so do accept the challenge. Get all the latest Pisces horoscope news including your weekly and monthly predictions
The Star
7 days ago
- Business
- The Star
Strathcona plans special dividend if takeover fails
A takeover of MEG would be the biggest acquisition yet for Strathcona. — Bloomberg NEW YORK: Strathcona Resources Ltd plans to issue a special dividend and increase the liquidity of shares traded should the company's takeover attempt of MEG Energy Corp fall through. Buying MEG is not 'Plan A' for Strathcona, chairman Adam Waterous said Monday about the Canadian oil company's C$6.6bil hostile takeover attempt of the rival oil sands producer. A failure won't be a major setback, he said. 'If we don't buy MEG, we'll probably issue a special dividend of about C$10 a share,' Waterous said. 'We're in a very fortunate situation that our status quo is extremely compelling.' In May, Strathcona offered about C$23.27 per MEG share in a cash-and-stock offer for the company shortly after agreeing to sell its assets in the Montney shale formation in western Canada in a C$2.8bil deal. Last month, MEG's board advised shareholders to reject Strathcona's bid, calling it inadequate and saying that combining with Strathcona would expose its investors to 'inferior assets'. The board also started a strategic review that may include finding other offers. A takeover of MEG, which Waterous called 'Plan A+', would be the biggest acquisition yet for Strathcona, which the former investment banker built through a flurry of deals over the past decade. The deal would make Strathcona a major heavy crude oil producer, adding MEG's roughly 100,000 barrels of daily output from its Christina Lake asset to Strathcona's projected 120,000 barrels of daily production. The proposal would provide MEG shareholders with synergies by being part of a larger company with multiple operations, and a successful takeover would upgrade Strathcona to investment grade and increase the company's liquidity so that the shares would be included on stock indexes, Waterous said. Strathcona became a public company two years ago through an all-share purchase of Pipestone Energy Corp, but 91% of the shares were held by Waterous Energy Fund through a series of partnerships. — Bloomberg
Yahoo
17-07-2025
- Business
- Yahoo
MEG Energy Announces Second Quarter of 2025 Results and Conference Call
CALGARY, AB, July 17, 2025 /CNW/ - Results Release: Thursday, July 31, 2025 after market close Conference Call Details: Friday, August 1, 2025 8:30am ET / 6:30am MT Dial-in Numbers: Toll Free: 1.800.715.9871 International: 1.647.932.3411 Replay: For those unable to dial-in to the conference call, an archived version will be available by 2:00pm ET / 12:00pm MT on Friday, August 1, 2025 at: About MEG MEG is the leading pure-play in situ thermal oil producer in Canada. Our purpose is to meet the growing demand for energy, produced safely and reliably, while generating long-term value for all our stakeholders. MEG produces, transports and sells our oil (AWB) to customers throughout North America and internationally. Our common shares are listed on the Toronto Stock Exchange under the symbol "MEG" (TSX: MEG). Learn more at For further information, please contact: Investor RelationsT 403.767.0515E invest@ Media RelationsT 403.775.1131E media@ SOURCE MEG Energy Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Cision Canada
17-07-2025
- Business
- Cision Canada
MEG Energy Announces Second Quarter of 2025 Results and Conference Call
CALGARY, AB, July 17, 2025 /CNW/ - Results Release: Thursday, July 31, 2025 after market close Conference Call Details: Friday, August 1, 2025 8:30am ET / 6:30am MT Dial-in Numbers: Toll Free: 1.800.715.9871 International: 1.647.932.3411 For those unable to dial-in to the conference call, an archived version will be available by 2:00pm ET / 12:00pm MT on Friday, August 1, 2025 at: About MEG MEG is the leading pure-play in situ thermal oil producer in Canada. Our purpose is to meet the growing demand for energy, produced safely and reliably, while generating long-term value for all our stakeholders. MEG produces, transports and sells our oil (AWB) to customers throughout North America and internationally. Our common shares are listed on the Toronto Stock Exchange under the symbol "MEG" (TSX: MEG). For further information, please contact: Investor Relations T 403.767.0515 E [email protected] Media Relations T 403.775.1131 E [email protected] SOURCE MEG Energy Corp.
India.com
06-07-2025
- Health
- India.com
Why Parkinson's Drug Fails Some Patients, New Technology Reveals Shocking Reason
Washington DC: Simon Fraser University Researchers are using an advanced brain imaging method called MEG to understand why Parkinson's drug levodopa doesn't work equally well for everyone. By mapping patients' brain signals before and after taking the drug, they discovered that it sometimes activates the wrong brain regions, dampening its helpful effects. This breakthrough could pave the way for personalised treatment strategies, ensuring patients receive medications that target the right areas of their brain more effectively. The new study by the Simon Fraser University (SFU) researchers, published in the journal Movement Disorders, looks at why levodopa - the main drug used in dopamine replacement therapy - is sometimes less effective in patients. The drug is typically prescribed to help reduce the movement symptoms associated with the neurodegenerative disorder. While it is effective in improving symptoms for the vast majority of patients, not everyone experiences the same level of benefit. In order to find out why this is the case, an SFU collaboration with researchers in Sweden has used magnetoencephalography (MEG) technology to determine how the drug affects signals in the brain. "Parkinson's is the second most prevalent neurodegenerative disease worldwide and it is the most rapidly increasing, in terms of incidence," says Alex Wiesman, assistant professor in biomedical physiology and kinesiology at SFU. "Treating this disease, both in terms of helping people with their symptoms, but also trying to find ways to reverse the effects, is becoming more and more important. If clinicians can see how levodopa activates certain parts of the brain in a patient, it can help to inform a more personalised approach to treatment," added Wiesman. The study was a collaboration with researchers at Karolinska Institute in Sweden, who used MEG to collect data from 17 patients with Parkinson's disease - a relatively small sample size. Researchers mapped participants' brain signals before and after taking the drug, in order to see how and where the drug impacted brain activity. MEG is an advanced non-invasive technology that measures the magnetic fields produced by the brain's electrical signals. It can help clinicians and researchers to study brain disorders and diseases, including brain injuries, tumours, epilepsy, autism, mental illness and more. Using this rare brain imaging technology, Wiesman and team developed a new analysis that lets them "search" the brain for off-target drug effects. "With this new way of analysing brain imaging data, we can track in real time whether or not the drug is affecting the right brain regions and helping patients to manage their symptoms," says Wiesman. "What we found was that there are sometimes 'off-target' effects of the drug. In other words, we could see the drug activating brain regions we don't want to be activating, and that's getting in the way of the helpful effects. We found that those people who showed 'off target' effects are still being helped by the drug, but not to the same extent as others," said Wiesman. Parkinson's disease is a neurodegenerative disorder, meaning parts of the brain become progressively damaged over time. It affects predominately the dopamine-producing neurons in a specific area of the brain called the substantia nigra. People with Parkinson's disease may experience a range of movement-related symptoms, such as tremors, slow movement, stiffness and balance problems. Wiesman hopes that a better understanding of how levodopa affects an individual's brain signals could improve how drugs are prescribed to treat Parkinson's. This new type of brain imaging analysis is not only for studying Parkinson's disease; any medications that affect brain signaling can be studied using the method developed by Wiesman and colleagues.
